Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
World J Surg Oncol ; 19(1): 42, 2021 Feb 09.
Article in English | MEDLINE | ID: mdl-33563292

ABSTRACT

BACKGROUND: Xpert Bladder Cancer is a detection method developed in recent years, designed with the functions of integrating sample automatically, nucleic acid amplification, and target sequence detection. It is a urine assay targeting five mRNAs (CRH, IGF2, UPK1B, ANXA10, and ABL1). The purpose of this article is to review the accuracy of Xpert Bladder Cancer in the follow-up diagnosis of bladder cancer and evaluate the role of Xpert Bladder Cancer in detecting the recurrence of non-muscle-invasive bladder cancer in the round. METHODS: In the database of Embase, PubMed, Web of Science, and Cochrane Library, the articles published up to October 13, 2020, were searched and screened based on the exclusion and inclusion criteria, and data were extracted from the included studies. The sensitivity, specificity, negative likelihood ratio, positive likelihood ratio summary of receiver operating characteristic curves, and diagnostic odds ratio were combined by the Meta-DiSc 1.4 software. The Stata 12.0 software was used to obtain the assessment of publication bias. RESULTS: A total of 8 articles involving eight fourfold tables were finally identified. The pooled sensitivity and specificity of Xpert Bladder Cancer in the diagnosis of bladder cancer were 0.71 and 0.81, respectively. The positive likelihood ratio and negative likelihood ratio were 3.74 and 0.34, respectively. The area under the curve was 0.8407. The diagnostic odds ratio was 11.99. Deeks' funnel plot asymmetry test manifested no publication bias. CONCLUSIONS: In summary, Xpert Bladder Cancer presents high accuracy and specificity in monitoring bladder cancer compared with cystoscopy. More researches are still required to further confirm this conclusion.


Subject(s)
Carcinoma , Urinary Bladder Neoplasms , Humans , Neoplasm Recurrence, Local/diagnosis , Neoplasm Recurrence, Local/genetics , Prognosis , RNA, Messenger/genetics , Sensitivity and Specificity , Urinary Bladder Neoplasms/diagnosis , Urinary Bladder Neoplasms/genetics
2.
J Mater Sci Mater Med ; 29(4): 38, 2018 Mar 21.
Article in English | MEDLINE | ID: mdl-29564568

ABSTRACT

Osteoclasts are large multinucleated giant cells that actively resorb bone during the physiological bone turnover (BTO), which is the continuous cycle of bone resorption (by osteoclasts) followed by new bone formation (by osteoblasts). Osteoclasts secrete chemotactic signals to recruit cells for regeneration of vasculature and bone. We hypothesize that a biomaterial that attracts osteoclasts and re-establishes BTO will induce a better healing response than currently used bone graft materials. While the majority of bone regeneration efforts have focused on maximizing bone deposition, the novelty in this approach is the focus on stimulating osteoclastic resorption as the starter for BTO and its concurrent new vascularized bone formation. A biodegradable tyrosine-derived polycarbonate, E1001(1k), was chosen as the polymer base due to its ability to support bone regeneration in vivo. The polymer was functionalized with a RGD peptide or collagen I, or blended with ß-tricalcium phosphate. Osteoclast attachment and early stages of active resorption were observed on all substrates. The transparency of E1001(1k) in combination with high resolution confocal imaging enabled visualization of morphological features of osteoclast activation such as the formation of the "actin ring" and the "ruffled border", which previously required destructive forms of imaging such as transmission electron microscopy. The significance of these results is twofold: (1) E1001(1k) is suitable for osteoclast attachment and supports osteoclast maturation, making it a base polymer that can be further modified to optimize stimulation of BTO and (2) the transparency of this polymer makes it a suitable analytical tool for studying osteoclast behavior.


Subject(s)
Bone Substitutes , Bone Transplantation , Bone and Bones/physiology , Osteoclasts/physiology , Animals , Bone Marrow Cells , Bone Regeneration , Cell Differentiation , Male , Osteoblasts , Rats , Rats, Sprague-Dawley
3.
Emerg Microbes Infect ; 13(1): 2353298, 2024 Dec.
Article in English | MEDLINE | ID: mdl-38721691

ABSTRACT

With the atypical rise of Mycoplasma pneumoniae infection (MPI) in 2023, prompt studies are needed to determine the current epidemic features and risk factors with emerging trends of MPI to furnish a framework for subsequent investigations. This multicentre, retrospective study was designed to analyse the epidemic patterns of MPI before and after the COVID-19 pandemic, as well as genotypes and the macrolide-resistance-associated mutations in MP sampled from paediatric patients in Southern China. Clinical data was collected from 1,33,674 patients admitted into investigational hospitals from 1 June 2017 to 30 November 2023. Metagenomic next-generation sequencing (mNGS) data were retrieved based on MP sequence positive samples from 299 paediatric patients for macrolide-resistance-associated mutations analysis. Pearson's chi-squared test was used to compare categorical variables between different time frames. The monthly average cases of paediatric common respiratory infection diseases increased without enhanced public health measures after the pandemic, especially for influenza, respiratory syncytial virus infection, and MPI. The contribution of MPI to pneumoniae was similar to that in the outbreak in 2019. Compared to mNGS data between 2019-2022 and 2023, the severity of MP did not grow stronger despite higher rates of macrolide-resistance hypervariable sites, including loci 2063 and 2064, were detected in childhood MP samples of 2023. Our findings indicated that ongoing surveillance is necessary to understand the impact of post pandemic on MP transmission disruption during epidemic season and the severity of clinical outcomes in different scenarios.


Subject(s)
COVID-19 , Mycoplasma pneumoniae , Pneumonia, Mycoplasma , Humans , Pneumonia, Mycoplasma/epidemiology , Pneumonia, Mycoplasma/microbiology , Mycoplasma pneumoniae/genetics , Mycoplasma pneumoniae/isolation & purification , Mycoplasma pneumoniae/drug effects , China/epidemiology , COVID-19/epidemiology , COVID-19/transmission , Child , Retrospective Studies , Child, Preschool , Male , Female , Infant , Macrolides/pharmacology , Drug Resistance, Bacterial , SARS-CoV-2/genetics , SARS-CoV-2/isolation & purification , Adolescent , High-Throughput Nucleotide Sequencing , Anti-Bacterial Agents/pharmacology , Pandemics
4.
PLoS One ; 17(5): e0268203, 2022.
Article in English | MEDLINE | ID: mdl-35594259

ABSTRACT

Betweenness centrality (BC) is widely used to identify critical nodes in a network by exploring the ability of all nodes to act as intermediaries for information exchange. However, one of its assumptions, i.e., the contributions of all shortest paths are equal, is inconsistent with variations in spatial interactions along these paths and has been questioned when applied to spatial networks. Hence, this paper proposes a spatial interaction incorporated betweenness centrality (SIBC) for spatial networks. SIBC weights the shortest path between each node pair according to the intensity of spatial interaction between them, emphasizing the combination of a network structure and spatial interactions. To test the rationality and validity of SIBC in identifying critical nodes and edges, two specific forms of SIBC are applied to the Shenzhen street network and China's intercity network. The results demonstrate that SIBC is more significant than BC when we also focus on the network functionality rather than only on the network structure. Moreover, the good performance of SIBC in robustness analysis illustrates its application value in improving network efficiency. This study highlights the meaning of introducing spatial configuration into empirical models of complex networks.

5.
Bioengineering (Basel) ; 9(5)2022 May 17.
Article in English | MEDLINE | ID: mdl-35621493

ABSTRACT

Here, we describe the characterization of tooth-germ organoids, three-dimensional (3D) constructs cultured in vitro with the potential to develop into living teeth. To date, the methods used to successfully create tooth organoids capable of forming functional teeth have been quite limited. Recently, hydrogel microparticles (HMP) have demonstrated utility in tissue repair and regeneration based on their useful characteristics, including their scaffolding ability, effective cell and drug delivery, their ability to mimic the natural tissue extracellular matrix, and their injectability. These outstanding properties led us to investigate the utility of using HMPs (average diameter: 158 ± 32 µm) derived from methacrylated gelatin (GelMA) (degree of substitution: 100%) to create tooth organoids. The tooth organoids were created by seeding human dental pulp stem cells (hDPSCs) and porcine dental epithelial cells (pDE) onto the HMPs, which provided an extensive surface area for the cells to effectively attach and proliferate. Interestingly, the cell-seeded HMPs cultured on low-attachment tissue culture plates with gentle rocking self-assembled into organoids, within which the cells maintained their viability and morphology throughout the incubation period. The self-assembled organoids reached a volume of ~50 mm3 within two weeks of the in vitro tissue culture. The co-cultured hDPSC-HMP and pDE-HMP structures effectively attached to each other without any externally applied forces. The presence of polarized, differentiated dental cells in these composite tooth-bud organoids demonstrated the potential of self-assembled dental cell HMPs to form tooth-bud organoid-like structures for potential applications in tooth regeneration strategies.

6.
Tissue Eng Part C Methods ; 25(9): 553-559, 2019 09.
Article in English | MEDLINE | ID: mdl-31418333

ABSTRACT

IMPACT STATEMENT: This work is a systematic evaluation of the experimental parameters of the most widely used in vitro recombinant human bone morphogenetic protein-2 (rhBMP-2) activity assays. The variations in assays reported in the literature have challenged the reproducibility and translation of work using rhBMP-2 as a bone-inducing growth factor. By elucidating the effect of model cell line on the dose-dependent alkaline phosphatase response to rhBMP-2 induction and by establishing a correlation between protein activity and protein concentration by enzyme-linked immunosorbent assay using commercially available rhBMP-2, this work is a significant step toward developing an in vitro-in vivo correlation between quantified activity and clinical efficacy.


Subject(s)
Biological Assay , Bone Morphogenetic Protein 2 , Animals , Bone Morphogenetic Protein 2/biosynthesis , Bone Morphogenetic Protein 2/chemistry , Bone Morphogenetic Protein 2/genetics , Bone Morphogenetic Protein 2/pharmacology , Cell Line , Drug Evaluation , Humans , Mice , Protein Stability , Recombinant Proteins/biosynthesis , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/pharmacology , Regenerative Medicine
SELECTION OF CITATIONS
SEARCH DETAIL